Monday's Underperforming Sectors: General Contractors & Builders, Pharmaceuticals
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
Updated: Sep 15 2025
0mins
Source: NASDAQ.COM
Market Performance: Drug shares are lagging behind the market, down approximately 1.4% overall, with significant declines from Cognition Therapeutics (down 27.9%) and Hyperion (down 19.2%).
Sector Laggards: The report also highlights general contractors and builders as part of the sectors underperforming on Monday.
Trade with 70% Backtested Accuracy
Stop guessing
"Should I Buy LEN.B?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Sign upAnalyst Views on LEN.B
Wall Street analysts forecast LEN.B stock price to rise
Wall Street analysts forecast LEN.B stock price to rise
Current: 101.340

Current: 101.340

About LEN.B
Lennar Corporation is a homebuilder and an originator of residential and commercial mortgage loans. The Company is also a provider of title insurance and closing services, and a developer of multifamily rental properties. The Company's segments include Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar others. Its Homebuilding segments primarily include the construction and sale of single-family attached and detached homes, as well as the purchase, development and sale of residential land directly and through its unconsolidated entities. The Company's Financial Services segment primarily provides mortgage financing, title and closing services primarily for buyers of its homes, as well as property and casualty insurance. The Company’s Multifamily segment is involved in the development, construction and property management of multifamily rental properties. its Lennar Other segment includes fund investments.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Truist Predicts Decline in Home Builder Revenue This Year, Yet Recommends These 4 Stocks for Purchase.
Home-builder revenue forecast: Home-builder revenue is expected to decline significantly in 2026 due to ongoing pressures in the housing market.
Investor opportunities: Despite the revenue drop, the situation presents a favorable opportunity for investors looking to target specific builders.
Builder Stocks Affected by Rising Mortgage Rates and Declining Sales; Upcoming Weeks Are Critical.
- Housing Market Rebound Delayed: The anticipated recovery in the housing market continues to be postponed, affecting investor confidence.
- Impact on Home Builders: Investors in home builders are experiencing financial strain due to the ongoing delays in the housing market recovery.
Home Builder Stocks Decline Following Cautious Forecasts from Lowe’s and Home Depot
- Home Builder Stocks Decline: Home builder stocks experienced a drop on Wednesday.
- Cautious Guidance from Retailers: Home improvement retailers provided cautious guidance, indicating limited prospects for significant housing market improvement this spring.
Dell, Heineken, and 28 Additional Selections for 2026 from the Barron’s Roundtable
Dramatic Start to 2026: The year has begun with significant tensions, likened to a transition from conflict to peace efforts.
Greenland's Political Situation: Greenland was on the verge of becoming the seventh state of New England, highlighting its unique geopolitical status.
Trump's Davos Speech Overlooked Housing Policy; Builders Benefit from Lack of Updates.
- Housing Stocks Reaction: Housing industry stocks rose following President Trump's speech in Davos.
- Lack of Surprises: The speech contained few surprises regarding housing policy, indicating stability in the sector.
Mortgage Rates Rise Again as Trade Concerns Push Treasury Yields Higher
- Mortgage Rate Increase: The cost of a 30-year mortgage rose by 0.14 percentage points due to recent bond-market fluctuations.
- Market Impact: The bond-market upheaval has disrupted expectations for lower mortgage rates.